市场调查报告书
商品编码
1499413
牙科骨移植片和替代品市场:按类型、产品、应用、最终用户划分 - 全球预测 2024-2030Dental Bone Grafts & Substitutes Market by Type (Allograft, Alloplast, Synthetic Bone Graft), Product (Bio-OSS, Grafton, OsteoGraf), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
牙科骨移植片和替代品市场规模预计2023年为11.4亿美元,2024年达到12.2亿美元,2030年达到18.7亿美元,复合年增长率预计为7.29%。
牙科骨移植片和替代品包括牙科手术中使用的产品和材料,以刺激骨生长并促进骨缺陷或缺失区域的骨再生。这些产品的材料包括人骨、动物骨和合成材料。牙周病、牙齿脱落和口腔疾病的增加增加了全世界老年人和成年人口的骨移植需求。口腔卫生和美学意识的提高也推动了市场的成长。然而,与移植物和替代物相关的高成本可能会让患者望而却步。此外,保险实务中牙科手术的覆盖范围有限也限制了市场的扩张。组织工程和再生医学的创新有助于增强移植材料的选择和程序。此外,3D 列印和人工智慧的采用不断增加,为未来几年移植和替代物的发展创造了新的机会。
主要市场统计 | |
---|---|
基准年[2023] | 11.4亿美元 |
预测年份 [2024] | 12.2亿美元 |
预测年份 [2030] | 18.7亿美元 |
复合年增长率(%) | 7.29% |
区域洞察
普及人口老化加剧、健康意识增强、对微创手术的偏好等,美洲牙科骨移植片和替代品有着广泛的市场。主要集中在生医材料研究和合成替代品开发以减少对人类和动物源产品的依赖的投资扩大了该地区的市场。在欧洲国家,完善的医疗保健系统和高医疗设备标准支持市场成长。同样,欧盟 (EU) 严格的法规环境可确保产品的安全性和有效性,并影响消费者对新技术的信心。由于医疗旅游业的增加和医疗基础设施的改善,中东牙科骨移植片市场正在成长。非洲地区在新兴医疗保健产业的成长方面落后,对技术进步的新投资可能是市场成长的潜在因素。在亚太地区,人口成长、政府对医疗保健的支持力度加大以及老年人对微创手术的偏好,为日本、中国和印度等国家的市场扩张铺平了道路。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在牙科骨移植片和替代品市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对牙科骨移植片和替代品市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该领域竞争性质的宝贵见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在牙科骨移植片和替代品市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[182 Pages Report] The Dental Bone Grafts & Substitutes Market size was estimated at USD 1.14 billion in 2023 and expected to reach USD 1.22 billion in 2024, at a CAGR 7.29% to reach USD 1.87 billion by 2030.
The dental bone grafts & substitutes include products and materials operated in dental surgery to stimulate bone growth and facilitate bone regeneration in areas with bone loss or deficiency. The source for the material of these products can be human bone, animal bone and synthetic material. Rising incidences of periodontal diseases, tooth loss, and oral ailments drive the need for bone graft procedures for the aged and adult population across the globe. Increased awareness about oral hygiene and aesthetic concerns also spur market growth. However, high cost associated with the grafts and substitutes can be prohibitive for patients. Additionally, limited coverage of dental procedures in the insurance sector restricts the spread of the market. Innovations in tissue engineering and regenerative medicine are helping in enhancing graft material options and procedures. In addition, rising incorporation of 3D printing and AI is creating new opportunity for the development of grafts and substitutes in the upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.14 billion |
Estimated Year [2024] | USD 1.22 billion |
Forecast Year [2030] | USD 1.87 billion |
CAGR (%) | 7.29% |
Regional Insights
The Americas have a sufficient market for dental bone grafts and substitutes due to the prevalence of the increased aged population, awareness about health, and preference for minimally invasive surgeries. Investments primarily focused on biomaterial research and the development of synthetic alternatives to reduce dependency on human and animal-derived products expanded the market in the region. In European countries, well-established healthcare systems and high medical device standards support the market's growth. Similarly, the stringent regulatory environment of the European Union ensures that products are safe and effective, influencing consumer confidence in newer technologies. The Middle East is experiencing growth in the dental bone grafts market due to increasing medical tourism and improving healthcare infrastructure. African regions have slow emerging healthcare sectors with new investments in technological advancements, which can be a potential element for the growth of the market. In the APAC region, increased population growth, growing governmental support for healthcare, and an aged population's preferences for minimally invasive surgeries paved the way for the spread of the market in countries such as Japan, China, and India.
Market Insights
The market dynamics represent an ever-changing landscape of the Dental Bone Grafts & Substitutes Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dental Bone Grafts & Substitutes Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dental Bone Grafts & Substitutes Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
ZimVie Inc. Expanded Dental Implant Solutions in Japan with Launch of TSX Implant
ZimVie Inc., a life sciences company in dental and spine solutions, announced the release of the TSX Implant in Japan. The TSX Implant, known for its suitability for immediate use post-extraction and effectiveness in both soft and dense bone. The implant has features such as peri-implant health, consistent bone maintenance at the crestal level, durable osseointegration, and prosthetic stability. [Published On: 2024-02-07]
Innovations in Bone Healing as Renovos Biologics Limited BMP-2 Gained FDA Recognition
Renovos Biologics Limited has received FDA approval for Renovite BMP-2, a cutting-edge synthetic nanoclay gel infused with bone morphogenic protein 2 (BMP-2). Renovite BMP-2 serves as an alternative to traditional bone grafts, facilitating precise and targeted bone regeneration while preventing BMP-2 leakage. The gel is formulated to degrade naturally as new bone tissue forms, enhancing safety and efficacy. [Published On: 2024-01-04]
Strategic Expansion in Bone Regeneration Technologies as Biocomposites Ltd. Acquired Artoss, Inc.
Artoss, Inc., a company in advanced bone graft substitutes employing its unique NanoBone technology acquired by Biocomposites Ltd. company officials highlighted this acquisition as pivotal, enhancing their portfolio with innovative, ready-to-use products and strengthening their position in bone regeneration and infection management solutions in orthopedic care. [Published On: 2023-06-14]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dental Bone Grafts & Substitutes Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Dental Bone Grafts & Substitutes Market, highlighting leading vendors and their innovative profiles. These include AlloSource, Baxter International Inc., BioHorizons, Inc, botiss biomaterials GmbH, Collagen Matrix, Inc., Dentium Co., Ltd, Dentsply Sirona, Geistlich Pharma AG, Hannox International Corp., immer Biomet Holdings, Inc., Institut Straumann AG, Integra LifeSciences Corporation, Johnson & Johnson, LIFENET HEALTH, INC., Maxigen Biotech Inc., Medtronic PLC, NovaBone Products, LLC by Halma plc, Orthofix Medical Inc., Osteogenics Biomedical, Inc., RTI Surgical, Inc., Stryker, and ZimVie Inc..
Market Segmentation & Coverage
TABLE 318